Sleep electroencephalographic response to muscarinic and serotonin(1A) receptor probes in patients with major depression and in normal controls

Biological Psychiatry

Volumn 44, Issue 1, 1998, Pages 21-33

  Seifritz, Erich ^a,b   Gillin, J Christian ^a,b   Rapaport, Mark H ^a,b   Kelsoe, John R ^a,b   Bhatti, Tahir ^a,b   Stahl, Stephen M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Acethylcholine; Cholinergic REM induction; Delta power; Delta sleep; Ipsapirone; Pathophysiology; Pilocarpine; Reciprocal interaction model; REM latency; Serotonin; Sigma power; Slow wave sleep; Spectral analysis of sleep electroencephalography

Indexed keywords

IPSAPIRONE; MUSCARINIC RECEPTOR; PILOCARPINE; PLACEBO; SEROTONIN RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DELTA RHYTHM; DEPRESSION; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; MALE; NEUROTRANSMITTER RELEASE; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; POLYSOMNOGRAPHY; PREMEDICATION; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REM SLEEP; SLEEP STAGE; SLOW WAVE SLEEP;

ADULT; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; DOWN-REGULATION; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOCARPINE; PLACEBOS; POLYSOMNOGRAPHY; PYRIMIDINES; RECEPTORS, MUSCARINIC; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SLEEP; SLEEP, REM; SYNAPTIC TRANSMISSION; UP-REGULATION;

EID: 0032124824     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00551-9     Document Type: Article

References (105)

1. Aston-Jones G., Bloom F.E. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J Neurosci. 1:1981;876-886.
2. Baghdoyan H.A., Lydic R., Callaway C.W., Hobson J.A. The carbachol-induced enhancement of desynchronized sleep signs is dose dependent and antagonized by centrally administered atropine. Neuropsychopharmacology. 2:1989;67-79.
3. Baghdoyan H.A., Spotts J.L., Snyder S.G. Simultaneous pontine and basal forebrain microinjections of carbachol suppress REM sleep. J Neurosci. 13:1993;229-242.
4. Beersma D.G.M., Achermann P. Changes of sleep EEG slow-wave activity in response to sleep manipulations To what extent are they related to changes in REM sleep latency? J Sleep Res. 4:1995;23-29.
5. Benca R.M., Obermayer W.H., Thisted R.A., Gillin J.C. Sleep and psychiatric disorders A meta-analysis . Arch Gen Psychiatry. 49:1992;651-668.
6. Berger M., Lund R., Bronisch T., Von Zerssen D. REM latency in neurotic and endogenous depression and the cholinergic REM induction test. Psychiatry Res. 10:1983;113-123.
7. Berger M., Höchli D., Zulley J. Cholinomimetic drug RS86, REM sleep, and depression [letter]. Lancet. i:1985;1385-1386.
8. Berger M., Riemann D., Höchli D., Spiegel R. The cholinergic REM sleep induction test with RS-86 State of trait-marker of depression? Arch Gen Psychiatry. 46:1989;421-428.
9. Berkowitz A., Sutton L., Janowsky D.S., Gillin J.C. Pilocarpine, an orally active muscarinic cholinergic agonist, induces REM sleep and reduces delta sleep in normal volunteers. Psychiatry Res. 33:1990;112-119.
10. Bhatti T., Gillin J.C., Seifritz E., Moore P., Clark C., Golshan S., et al. Effects of a tryptophan-free amino acid drink challenge on normal human sleep EEG and mood. Biol Psychiatry. 43:1998;52-59.
11. Borbély A.A., Trachsel L., Tobler I. Effect of ritanserin on sleep stages and sleep EEG in the rat. Eur J Pharmacol. 156:1988;275-278.
12. Buzsaki G., Bickford R.G., Ponomareff G., Thal L.J., Mandel R., Gage F.H. Nucleus basalis and thalamic control of neocortical activity in the freely moving rat. J Neurosci. 8:1988;4007-4026.
13. Calvo J.M., Simon-Arceo K., Fernandez-Mas R. Prolonged enhancement of REM sleep produced by carbachol microinjection into the amygdala. Neuroreport. 7:1996;577-580.
14. 1 binding sites in depressed suicides. Psychopharmacology. 102:1990;544-548.
15. Contreras D., Steriade M. Spindle oscillation in cats The role of corticothalamic feedback in a thalamically generated rhythm . J Physiol. 490:1996;159-179.
16. Contreras D., Steriade M. Synchronization of low-frequency rhythms in corticothalamic networks. Neuroscience. 76:1997;11-24.
17. 1A receptor sensitivity in major depression. A neuroendocrine study with buspirone. Br J Psychiatry. 164:1994;372-379.
18. Curró Dossi R., Paré D., Steriade M. Short-lasting nicotinic and long-lasting muscarinic depolarizing responses of thalamocortical neurons to stimulation of mesopontine cholinergic nuclei. J Neurophysiol. 65:1990;393-406.
19. 2 antagonist, and temazepam on human sleep stages and EEG power spectra. Eur J Pharmacol. 171:1989;207-218.
20. Dijk D.J., Hayes B., Czeisler C.A. Dynamics of electroencephalographic sleep episodes and slow wave activity in men Effect of sleep deprivation . Brain Res. 626:1993;190-199.
21. Dilsaver S.C. Cholinergic mechanisms in depression. Brain Res. 396:1986;285-316.
22. 5) expressed in baclovirus-infected insect cells. J Pharmacol Exp Ther. 274:1995;378-384.
23. 1A agonist, on sleep patterns of healthy subjects. Psychopharmacology. 117:1995;186-192.
24. Dubé S., Kumar N., Ettedgui E., Pohl R., Jones D., Sitaram N. Cholinergic REM induction response Separation of anxiety and depression . Biol Psychiatry. 20:1985;408-418.
25. 2 receptors in the modulation of the sleep/wakefulness states. J Sleep Res. 1:1992;163-168.
26. Foote S.L., Bloom F.E., Aston-Jones G. Nucleus locus coeruleus New evidence of anatomical and physiological specificity . Physiol Rev. 63:1983;844-914.
27. Fritze J. The adrenergic-cholinergic imbalance hypothesis of depression A review and a perspective . Rev Neurosci. 4:1993;63-93.
28. George R., Haslett W.L., Jenden D.J. A cholinergic mechanism in the pontine reticular formation Induction of paradoxical sleep . J Neuropharmacol. 3:1964;541-552.
29. Giles D.E., Biggs M.M., Rush A.J., Roffwarg H.P. Risk factors in families of unipolar depression. I. Psychiatric illness and reduced REM latency. J Affect Disord. 14:1988;51-59.
30. Gillin J.C., Sitaram N., Mendelson W.B., Wyatt R.J. Physostigmine alters onset but not duration of REM sleep in man. Psychopharmacology. 58:1978;111-114.
31. Gillin J.C., Sitaram N., Duncan W.C. Muscarinic supersensitivity A possible model for the sleep disturbance of primary depression? Psychiatry Res. 1:1979;17-22.
32. Gillin J.C., Kelsoe J.R., Kaufman C.A., Kleinman J.E., Risch S.C., Janowsky D.S. Muscarinic receptor density in skin fibroblasts and autopsied brain tissue in affective disorder. Ann NY Acad Sci. 487:1986;143-149.
33. Gillin J.C., Smith T.L., Irwin M., Kripke D.F., Brown S., Schuckit M. Short REM latency in primary alcoholic patients with secondary depression. Am J Psychiatry. 147:1990;106-109.
34. Gillin J.C., Smith T.L., Irwin M., Kripke D.F., Schuckit M. EEG sleep studies in "pure" primary alcoholism during subacute withdrawal Relationships to normal controls, age, and other clinical variables . Biol Psychiatry. 27:1990;477-488.
35. Gillin J.C., Sutton L., Ruiz C., Darko D., Golshan S., Risch S.C., et al. The effects of scopolamine on sleep and mood in depressed patients with a history of alcoholism and a normal comparison group. Biol Psychiatry. 30:1991;157-169.
36. Gillin J.C., Sutton L., Ruiz C., Golshan S., Hirsch S., Warmann C., et al. Dose dependent inhibition of REM sleep in normal controls by biperiden, a muscarinic antagonist. Biol Psychiatry. 30:1991;151-156.
37. Gillin J.C., Sutton L., Ruiz C., Kelsoe J., Dupont R.M., Darko D., et al. The cholinergic rapid eye movement induction test with arecoline in depression. Arch Gen Psychiatry. 48:1991;264-270.
38. 1A agonist in normal volunteers. Psychopharmacology. 116:1994;433-436.
39. 1A agonist, suppresses REM sleep equally in unmedicated depressed patients and normal controls. Neuropsychopharmacology. 15:1996;109-115.
40. Heninger G.R., Delgado P.L., Charney D.S. The revised monoamine theory of depression A modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans . Pharmacopsychiatry. 29:1996;2-11.
41. Hobson J.A., McCarley R.W., Wyzinski P.W. Sleep cycle oscillation Reciprocal discharge by two brainstem neuronal groups . Science. 189:1975;55-58.
42. Hohagen F., Riemann D., Spiegel R., Holzhauer M., Berger M. Influence of the cholinergic agonist SDZ 210-086 on sleep in healthy subjects. Neuropsychopharmacology. 9:1993;225-232.
43. Holsboer-Trachsler E., Hatzinger M., Stohler R., Hemmeter U., Gray J., Müller J., et al. Effects of the novel acetylcholinesterase inhibitor SDZ ENA 713 on sleep in man. Neuropychopharmacology. 8:1993;87-92.
44. Honda T., Semba K. Serotonergic synaptic input to cholinergic neurons in the rat mesopontine tegmentum. Brain Res. 47:1994;299-306.
45. Janowsky D.J., El-Youseff M.K., Davis J.M. A cholinergic-adrenergic hypothesis of mania and depression. Lancet. ii:1972;632-635.
46. Johnson L.C., Burdick A., Smith J. Sleep during alcohol intake and withdrawal in the chronic alcoholic. Arch Gen Psychiatry. 22:1970;406-418.
47. Jones B.E. Paradoxical sleep and its chemical/structural substrates in the brain. Neuroscience. 40:1991;637-656.
48. Jones D., Kewala S., Bell S., Dubé S., Jackson E., Sitaram N. Cholinergic REM induction response correlation with endogenous major depressive subtype. Psychiatry Res. 14:1985;99-110.
49. Keshavan M., Jones D.A., Dubé S., Grabowski J., Bell J., Sitaram N. Cardioacceleratory responses to arecoline infusion during sleep in depressive, anxious, and normal subjects. Biol Psychiatry. 22:1987;1473-1477.
50. Krieg J.C., Berger M. REM sleep and cortisol response to the cholinergic challenge with RS86 in normals and depressives. Acta Psychiatr Scand. 76:1987;600-602.
51. Kupfer D.J., Ehlers C.L. Two roads to rapid eye movement latency. Arch Gen Psychiatry. 46:1989;945-948.
52. Landolt H.P., Roth C., Dijk D.J., Borbély A.A. Late-afternoon ethanol intake affects nocturnal sleep and the sleep EEG in middle-aged men. J Clin Psychopharmacol. 16:1996;428-436.
53. Lauriello J., Kenny W.M., Sutton L., Golshan S., Ruiz C., Kelsoe J., et al. The cholinergic REM sleep induction test with pilocarpine in mildly depressed patients and normal controls. Biol Psychiatry. 33:1993;33-39.
54. Leonard C.S., Llinas R. Serotonergic and cholinergic inhibition of mesopontine cholinergic neurons controlling REM sleep An in vivo electrophysiological study . Neuroscience. 59:1994;309-330.
55. 1A) receptor-mediated hypothermic response to ipsapirone in unipolar depression. Life Sci. 46:1990;1271-1277.
56. 1A receptor responsivity in unipolar depression. Evaluation of ipsapirone-induced ACTH and cortisol secretion in patients and controls. Biol Psychiatry. 28:1990;620-628.
57. Luebke J.I., Greene R.W., Semba K., Kamondi A., McCarley R.W., Reiner P.B. Serotonin hyperpolarizes cholinergic low-threshold burst neurons in the rat laterodorsal tegmental nucleus in vitro. Proc Natl Acad Sci USA. 89:1992;743-747.
58. Maes M., Meltzer H.Y. The serotonin hypothesis of major depression. Bloom F.E., Kupfer D.J. Psychopharmacology The Fourth Generation of Progress . 1995;933-944 Raven Press, New York.
59. Manfridi A., Mancia M. Desynchronized (REM) sleep inhibition induced by carbachol microinjections into the nucleus basalis of Meynert is mediated by the glutamatergic system. Exp Brain Res. 109:1996;174-178.
60. 1A binding sites in frontal cortex of suicide victims . J Neural Transm. 85:1991;181-194.
61. McCarley R.W. REM sleep and depression Common neurobiological control mechanisms . Am J Psychiatry. 139:1982;565-570.
62. McCarley R.W., Hobson J.A. Neuronal excitability modulation over the sleep cycle A structural and mathematical model . Science. 189:1975;58-60.
63. McCormick D.A., Prince D.A. Actions of acetylcholine in the guinea pig and cat medial and lateral geniculate nuclei. J Physiol. 392:1987;147-165.
64. McCormick D.A., Wang Z. Serotonin and noradrenaline excite GABAergic neurones of the guinea-pig and cat nucleus reticularis thalami. J Physiol. 442:1991;235-255.
65. McGinty D.J., Harper R.M. Dorsal raphe neurons Depression of firing during sleep in cats . Brain Res. 101:1976;569-575.
66. Meltzer H.Y., Maes M. Effects of buspirone on plasma prolactin and cortisol levels in major depressed and normal subjects. Biol Psychiatry. 35:1994;316-323.
67. Meltzer H.Y., Maes M. Effects of ipsapirone on plasma cortisol and body temperature in major depression. Biol Psychiatry. 38:1995;450-457.
68. Mendelson W.B., Sitaram N., Wyatt R.J., Gillin J.C. Methscopolamine inhibition of sleep-related growth hormone secretion Evidence for a cholinergic secretory mechanism . J Clin Invest. 61:1978;1683-1690.
69. Moeller F.G., Gillin J.C., Irwin M., Golshan S., Kripke D.F., Schuckit M. A comparison of sleep EEGs in patients with primary major depression and major depression secondary to alcoholism. J Affect Disord. 27:1993;39-42.
70. Moeller F.G., Steinberg J.L., Fulton M., Kramer G., Petty F. A preliminary neuroendocrine study with buspirone in major depression. Neuropsychopharmacology. 10:1994;75-83.
71. Moore P, Gillin JC, Bhatti T, Seifritz E, Clark C, Stahl SM, et al (in press): Rapid tryptophan depletion affects sleep EEG but not mood in fully remitted depressed men on serotonin reuptake inhibitors. Arch Gen Psychiatry.
72. Nurnberger J.I., Jimerson D.C., Simmons-Alling M.S.N., Tamminga C., Nadi N.S., Lawrence D., et al. Behavioral, physiological, and neuroendocrine responses to arecoline in normal twins and "well state' bipolar patients. Psychiatry Res. 9:1983;191-200.
73. Nurnberger J.I., Berrettini W., Mendelson W.B., Sack D., Gershon E.S. Measuring cholinergic sensitivity I Arecoline effects in bipolar patients . Biol Psychiatry. 25:1989;610-617.
74. Owens M.J., Nemeroff C.B. Role of serotonin in the pathophysiology of depression Focus on the serotonin transporter . Clin Chem. 40:1994;288-295.
75. Rechtschaffen A., Kales A. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. 1968;Department of Health, Education and Welfare, Neurological Information Network, Bethesda, MD.
76. Riemann D., Berger M. EEG sleep in depression and in remission and the REM sleep response to the cholinergic agonist RS86. Neuropsychopharmacology. 2:1989;145-152.
77. Riemann D., Hohagen F., Fleckenstein P., Schredl M., Berger M. The cholinergic REM induction test with RS 86 after scopolamine pretreatment in healthy subjects. Psychiatry Res. 38:1991;247-260.
78. Riemann D., Gann H., Dressing H., Müller W.E., Aldenhoff J.B. Influence of the cholinesterase inhibitor galanthamine hydrobromide on normal sleep. Psychiatry Res. 51:1994;253-267.
79. Riemann D., Hohagen F., Bahro M., Berger M. Sleep in depression The influence of age, gender and diagnostic subtype on baseline sleep and the cholinergic REM induction test with RS 86 . Eur Arch Psychiatry Clin Neurosci. 243:1994;279-290.
80. Sakai K., Koyama Y. Are there cholinergic and non-cholinergic paradoxical sleep-on neurones in the pons? Neuroreport. 7:1996;2449-2453.
81. Sanford L.D., Ross R.J., Seggos A.E., Morrison A.R., Ball W.A., Mann G.L. Central administration of two 5-HT receptor agonists Effect on REM sleep initiation and PGO waves . Pharmacol Biochem Behav. 49:1994;93-100.
82. Schreiber W., Lauer C.J., Krumrey K., Holsboer F., Krieg J.C. Cholinergic REM sleep induction test in subjects at high risk for psychiatric disorders. Biol Psychiatry. 32:1992;79-90.
83. 2 blockade. Neurosci Lett. 209:1996;41-44.
84. 1A antagonist pindolol Possible disinhibition of raphe neuron activity . Brain Res. 759:1997;84-91.
85. Shiromani P.J., Malik M., Winston S., McCarley R.W. Time course of fos-like immunoreactivity associated with cholinergically induced REM sleep. J Neurosci. 15:1995;3500-3508.
86. Sitaram N., Wyatt R.J., Dawson S., Gillin J.C. REM sleep induction by physostigmine infusion during sleep. Science. 191:1976;1281-1286.
87. Sitaram N., Mendelson W.B., Wyatt R.J., Gillin J.C. The time-dependent induction of REM sleep and arousal by physostigmine infusion during normal human sleep. Brain Res. 122:1977;562-567.
88. Sitaram N., Moore A.M., Gillin J.C. Experimental acceleration and slowing of REM sleep ultradian rhythm by cholinergic agonist and antagonist. Nature. 274:1978;490-492.
89. Sitaram N., Moore A.M., Gillin J.C. Scopolamine-induced muscarinic supersensitivity in normal man Changes in sleep . Psychiatry Res. 1:1979;9-16.
90. Sitaram N., Moore A.M., Vanskiver C., Blendy J., Nurnberger J.I., Gershon E.S., et al. Hypersensitive cholinergic functioning in primary affective illness. Pepeu G., Ladinsky H. Cholinergic Mechanisms. 1980;947-962 Plenum Press, New York.
91. Sitaram N., Nurnberger J.I., Gershon E.S., Gillin J.C. Faster cholinergic REM sleep induction in euthymic patients with primary affective illness. Science. 208:1980;200-202.
92. Sitaram N., Nurnberger J.I., Gershon E.S., Gillin J.C. Cholinergic regulation of mood and REM sleep Potential marker of vulnerability to affective disorder . Am J Psychiatry. 139:1982;571-576.
93. Sitaram N., Dubé S., Keshavan M., Davies A., Reynal P. The association of supersensitive cholinergic REM-induction and affective illness within pedigrees. J Psychiatr Res. 21:1987;487-497.
94. Spiegel R. Effects of RS86, an orally active cholinergic agonist, on sleep in man. Psychiatry Res. 11:1984;1-13.
95. Steriade M., Curró Dossi R., Nuñez A. Network modulation of a slow intrinsic oscillation of cat thalamocortical neurons implicated in sleep delta waves Cortically induced synchronization and brainstem cholinergic suppression . J Neurosci. 11:1991;3200-3217.
96. Steriade M., Amzica F., Nuñez A. Cholinergic and noradrenergic modulation of the slow (≈0.3 Hz) oscillation in neocortical cells. J Neurophysiol. 70:1993;1385-1400.
97. Steriade M., McCormick D.A., Seijnowsky T.J. Thalamocortical oscillations in the sleeping and the aroused brain. Science. 262:1993;679-685.
98. Stewart D.J., MacFabe D.F., Vanderwolf C.H. Cholinergic activation of the electroencephalogram Role of the substantia innominata and effects of atropine and quinuclidinyl benzilate . Brain Res. 322:1984;219-232.
99. Stockmeier C.A., Dilley G.E., Shapiro L.A., Overholser J.C., Thompson P.A., Meltzer H.Y. Serotonin receptors in suicide victims with major depression. Neuropsychopharmacology. 16:1997;162-173.
100. Swanson L.W., Mogenson G.J., Gerfen C.R., Robinson P. Evidence for a projection from the lateral preoptic area and substantia innominata to the "mesencephalic locomotor region' in the rat. Brain Res. 295:1984;161-178.
101. Uchida S., Maloney T., March J.D., Azari R., Feinberg I. Sigma (12-15 Hz) and delta (0.3-3 Hz) EEG oscillate reciprocally within NREM sleep. Brain Res Bull. 27:1991;93-96.
102. Vanderwolf C.H., Raithby A., Snider M., Cristi C., Tanner C. Effects of some cholinergic agonists on neocortical slow wave activity in rats with basal forebrain lesions. Brain Res Bull. 31:1993;515-521.
103. 2-muscarinic receptors How does ligand binding affinity relate to intrinsic activity? J Rec Sign Transd Res. 16:1996;135-148.
104. 2 muscarinic receptor agonists on REM sleep generation. Brain Res. 503:1989;128-131.
105. Wager S., Robinson D., Goetz R., Nunes E., Gully R., Quitkin R. Cholinergic REM sleep induction in atypical depression. Biol Psychiatry. 27:1990;441-446.